PharmaEssentia Corporation PharmaEssentia Corporation

PharmaEssentia Corporation

6446

Classement en actions #1448
PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing... PharmaEssentia Corporation is a biopharmaceutical firm dedicated to developing therapies for human ailments, serving both the Taiwanese and international markets. Its product portfolio prominently features Ropeginterferon alfa-2b, indicated for the management of various hematological conditions including chronic myelogenous leukemia, T-Cell leukemia, early myelofibrosis, polycythemia vera, and essential thrombocythemia. Beyond this, the company's pipeline includes TCRT, anti PD-1, PEG-cytokine X,Y, and novel checkpoint antibodies, all under development for solid tumors. A specific combination, P1101 + anti PD-1, is being explored for hepatocellular carcinoma, while PEG-GCSF addresses neutropenia. Fundamentally, its comprehensive research and development initiatives span key therapeutic areas such as hematology, infectious diseases, and oncology. Established in 1990, PharmaEssentia Corporation maintains its headquarters in Taipei, Taiwan.
Prix de l'action
$35.96
Capitalisation boursière
$14.87B
Changement (1 jour)
-0.85%
Changement (1 an)
138.77%
Pays
TW
Échange PharmaEssentia Corporation (6446)

Catégorie

Healthcare
Historique du prix de l'action pour PharmaEssentia Corporation (6446)
Prix de clôture le plus élevé : $37.51 le 2026-10-01

Prix de clôture le plus bas : $4.95 le 2014-03-01
Historique du prix de l'action de PharmaEssentia Corporation de 2014 à 2026
Performance annuelle du prix de l'action
Année Performance
2026 (TTM) 78.21%
2025 -1.54%
2024 65.30%
2023 -34.57%
2022 52.79%
2021 220.53%
2020 2.39%
2019 -41.63%
2018 21.23%
2017 -8.25%
2016 -3.31%
2015 21.68%
2014 0.00%
Prix de l'action pour des entreprises similaires ou concurrentes
Entreprise Prix de l'action Variation 1a% Pays
$171.67 -
DE
$164.18 22.78%
DE
$40.45 43.11%
JP
$223.65 30.61%
CH
$18.43 -4.03%
IN